Latanoprost/Timolol Zentiva

Timolol maleate and latanoprost, the active ingredients in Latanoprost/Timolol Zentiva, are a beta‑blocker/prostaglandin analog combination presented as eye drops for ocular use. They lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost/Timolol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Latanoprost/Timolol Zentiva is used in the management of ocular conditions that require reduction of intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. Ocular hypertension: lowers eye pressure to reduce risk of progression to glaucoma. Secondary glaucoma: helps control pressure when monotherapy is insufficient.

Latanoprost/Timolol Zentiva may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision. - Redness of the eye (hyperemia). - Itching or mild allergic reaction on the eyelid. - Dry eye sensation. - Foreign body feeling.

Serious or Rare Side Effects: - Severe allergic reaction with swelling of the eyelid or face. - Sudden loss of vision. - Marked decrease in heart rate or low blood pressure. - Exacerbation of asthma or bronchospasm. - Persistent eye pain unresponsive to treatment.

Before using Latanoprost/Timolol Zentiva, consider the following precautions.

Pregnancy: consult a healthcare professional as safety has not been established. Breastfeeding: use with caution; potential exposure to the infant is unknown. Cardiovascular disease: monitor heart rate and blood pressure due to beta‑blocker effects. Respiratory disorders: avoid in patients with asthma or severe COPD because of possible bronchospasm. Drug interactions: review concomitant medications for potential additive beta‑blockade or prostaglandin effects. Store at room temperature: keep below 25 °C in the original container, protected from light and moisture.

Latanoprost/Timolol Zentiva can interact with other medicines; notable interactions include.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: may cause excessive bradycardia or hypotension. - Inhaled sympathomimetics (e.g., epinephrine): may reduce ocular efficacy. - Other prostaglandin analog eye drops: risk of additive ocular side effects. - Calcium channel blockers: may enhance intra‑ocular pressure‑lowering effect leading to over‑reduction. - Monoamine oxidase inhibitors: may increase risk of bronchospasm.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may diminish pressure‑lowering response. - Anticholinergic eye drops: may affect pupil size and drug absorption. - Systemic antihypertensives: monitor for additive blood pressure lowering. - NSAID eye preparations: watch for increased ocular irritation. - Diuretics: observe for electrolyte disturbances in susceptible patients.